Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation

Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation

10.3389/fimmu.2022.805558

Saved in:
Bibliographic Details
Main Authors: Liu, X, Li, X, Chen, L, Hsu, ACY, Asquith, KL, Liu, C, Laurie, K, Barr, I, Foster, PS, Yang, M
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: Frontiers Media SA 2022
Subjects:
STAT1 and fludarabine
asthma exacerbation
inflammation
influenza infection
pathway analysis
proteomics
steroid-resistance
Online Access:https://scholarbank.nus.edu.sg/handle/10635/219156
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-219156
record_format dspace
spelling sg-nus-scholar.10635-2191562023-11-01T09:00:36Z Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation Liu, X Li, X Chen, L Hsu, ACY Asquith, KL Liu, C Laurie, K Barr, I Foster, PS Yang, M DUKE-NUS MEDICAL SCHOOL STAT1 and fludarabine asthma exacerbation inflammation influenza infection pathway analysis proteomics steroid-resistance 10.3389/fimmu.2022.805558 Frontiers in Immunology 13 805558- 2022-04-13T08:22:14Z 2022-04-13T08:22:14Z 2022-02-25 2022-04-13T07:27:34Z Article Liu, X, Li, X, Chen, L, Hsu, ACY, Asquith, KL, Liu, C, Laurie, K, Barr, I, Foster, PS, Yang, M (2022-02-25). Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation. Frontiers in Immunology 13 : 805558-. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2022.805558 1664-3224 1664-3224 https://scholarbank.nus.edu.sg/handle/10635/219156 Frontiers Media SA Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic STAT1 and fludarabine
asthma exacerbation
inflammation
influenza infection
pathway analysis
proteomics
steroid-resistance
spellingShingle STAT1 and fludarabine
asthma exacerbation
inflammation
influenza infection
pathway analysis
proteomics
steroid-resistance
Liu, X
Li, X
Chen, L
Hsu, ACY
Asquith, KL
Liu, C
Laurie, K
Barr, I
Foster, PS
Yang, M
Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation
description 10.3389/fimmu.2022.805558
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Liu, X
Li, X
Chen, L
Hsu, ACY
Asquith, KL
Liu, C
Laurie, K
Barr, I
Foster, PS
Yang, M
format Article
author Liu, X
Li, X
Chen, L
Hsu, ACY
Asquith, KL
Liu, C
Laurie, K
Barr, I
Foster, PS
Yang, M
author_sort Liu, X
title Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation
title_short Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation
title_full Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation
title_fullStr Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation
title_full_unstemmed Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation
title_sort proteomic analysis reveals a novel therapeutic strategy using fludarabine for steroid-resistant asthma exacerbation
publisher Frontiers Media SA
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/219156
_version_ 1781793056149733376

Similar Items